Published • loading... • Updated
AstraZeneca’s Cancer Drug Combo Hits Main Survival Goal in Late-Stage Trial
Summary by WTVB
4 Articles
4 Articles
AstraZeneca’s drug combo helps lung cancer patients live longer in late-stage study - Regional Media News
Sept 8 (Reuters) - AstraZeneca said on Tuesday its cancer drug, Imfinzi, combined with Amgen's targeted immunotherapy, Imdelltra, significantly improved overall survival of extensive-stage small-cell lung cancer patients in a late-stage trial. Here are some details: • The trial tested the combination as a maintenance [...]
AstraZeneca’s cancer drug combo hits main survival goal in late-stage trial
Sept 8 (Reuters) - AstraZeneca said on Tuesday its cancer drug Imfinzi combined with Amgen's targeted immunotherapy Imdelltra significantly improved overall survival in first-line extensive-stage small cell lung cancer in a late-stage ...
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
